Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Eur J Pharm Biopharm ; 136: 231-239, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30703545

RESUMEN

In this paper we determined the solubility limits of the amorphous flutamide within the two different polymeric matrixes - poly vinylpyrrolidone and poly vinylacetate. In order to achieve this goal, series of broadband dielectric spectroscopy measurements were performed. As a result we found that the maximal amount of the drug that can be successfully dissolved within the PVAc (maintaining the non-supersaturated conditions) is equal to 35 wt% of the amorphous solid dispersion system. Interestingly enough similar results, in terms of solubility limits, were achieved utilizing significantly higher amount of the pharmaceutical - 71 wt% - in the PVP matrix. Accordingly, we established the following relationship in the solubility limits of the amorphous flutamide dispersed within examined polymer matrixes: PVP > PVAc. It is worth highlighting that in order to preserve the thermodynamic stability - one of the two contributors to the physical stability - drug loading in the amorphous solid dispersion system should not exceed its solubility limits. Hence, choosing appropriate amount of the polymer addition will determine if obtained system remains physically stable. Subsequently, we presented the "stability maps" for all investigated FL-based ASD systems from which one might predict the stabilization effect exerted by certain amount of polymer.


Asunto(s)
Calorimetría/métodos , Espectroscopía Dieléctrica/métodos , Portadores de Fármacos/química , Flutamida/química , Polímeros/química , Antagonistas de Andrógenos/análisis , Antagonistas de Andrógenos/química , Portadores de Fármacos/análisis , Flutamida/análisis , Polímeros/análisis , Solubilidad
2.
Mol Pharm ; 14(10): 3370-3380, 2017 10 02.
Artículo en Inglés | MEDLINE | ID: mdl-28787567

RESUMEN

In this paper, a novel approach to determine stable concentration in API-polymer systems is presented. As a model, binary amorphous mixtures flutamide (FL) drug with a copolymer Kollidon VA64 (PVP/VA) have been used. It is worthwhile to note that finding an effective method to achieve this goal is a matter of great importance because physical stability of the amorphous pharmaceuticals is the key issue that is investigated worldwide. Due to the fact that molecular dynamics was found to be the crucial factor affecting physical stability of disordered pharmaceuticals, we examined it for both neat FL and its PVP/VA mixtures by means of broadband dielectric spectroscopy (BDS). Thorough investigation of the impact of polymeric additive on the molecular mobility of disordered FL reveals unusual, previously unreported behavior. Namely, simultaneously with the beginning of the recrystallization process, we observe some transformation from unstable supersaturated concentration of investigated mixture to the different, unknown concentration of FL-PVP/VA. Observed, during BDS experiment, transformation enables us to determine the limiting, highly physically stable concentration of FL in PVP/VA polymer (saturated solution), which is equivalent to FL + 41% wt. of PVP/VA. The described high physical stability of this unveiled system has been confirmed by means of long-term XRD measurements. According to our knowledge, this is the first time when such a behavior has been observed by means of BDS.


Asunto(s)
Espectroscopía Dieléctrica/métodos , Estabilidad de Medicamentos , Rastreo Diferencial de Calorimetría , Química Farmacéutica/métodos , Cristalización , Flutamida/química , Modelos Químicos , Pirrolidinas/química , Solubilidad , Termodinámica , Compuestos de Vinilo/química
3.
Adv Exp Med Biol ; 975 Pt 1: 515-534, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28849479

RESUMEN

Taurine, the most abundant free amino acid in leukocyte cytosol traps hypohalous acids (HOCl and HOBr) to produce N-chlorotaurine (taurine chloramine, NCT and N-bromotaurine (taurine bromamine, Tau-NHBr,) respectively. Both haloamines show anti-inflammatory and antimicrobial properties. However, the therapeutic applicability of Tau-NHBr is limited due to its relatively poor stability. To overcome this disadvantage, we have synthesized the stable N-bromotaurine compounds N-monobromo-2,2-dimethyltaurine (Br-612) and N-dibromo-2,2-dimethyltaurine (Br-422). The aim of this study was to compare anti-inflammatory and microbicidal properties of Br-612 and Br-422 with that of Tau-NHBr and bromamine T (BAT). We have shown that all the tested compounds show similar anti-inflammatory properties. Importantly, the stable N-bromotaurine compounds exerted even stronger microbicidal activity than Tau-NHBr. Finally, for the purpose of topical application of these compounds we have developed a carbomer-based bioadhesive solid dosage form of BAT and Br-612, featuring sustained release of the active substance.


Asunto(s)
Antiinfecciosos/farmacología , Antiinflamatorios/farmacología , Bromuros/farmacología , Taurina/farmacología , Animales , Antiinfecciosos/síntesis química , Antiinfecciosos/química , Antiinflamatorios/síntesis química , Antiinflamatorios/química , Estabilidad de Medicamentos , Ratones , Sulfonamidas/farmacología
4.
Int J Pharm ; 404(1-2): 169-75, 2011 Feb 14.
Artículo en Inglés | MEDLINE | ID: mdl-21095225

RESUMEN

A comprehensive study was conducted to investigate the effects of carrageenans, and hydroxypropylmethylcellulose (HPMC) on the properties of hydrodynamically balanced systems (HBS) containing L-dopa as a model drug. The novel integrated approach included measurements of: solvent uptake, erosion, apparent density and changes in the internal structure of dosage forms during dissolution test by means of a USP4 compatible MRI. Differences in water ingress into the matrices with pure carrageenans (ι, κ, λ) or low viscous HPMC, were detected by non-invasive magnetic resonance imaging. Matrices based on carrageenans subjected to rapid hydration and erosion, were not able to maintain satisfactory floating properties for a sufficiently long period of time. The application of carrageenans in mixtures with HMC promoted water uptake by HBS formulations. The effect produced by varying the polymer blend's composition on release of the L-dopa was also studied. Dissolution data was fitted to Korsmeyer-Peppas equation. For matrices containing mixtures of carrageenan and HPMC, the linear increase in the releasing rate constant, K, with the carrageenan content in the matrix was observed.


Asunto(s)
Carragenina/química , Portadores de Fármacos , Levodopa/administración & dosificación , Metilcelulosa/análogos & derivados , Administración Oral , Química Farmacéutica , Formas de Dosificación , Composición de Medicamentos , Derivados de la Hipromelosa , Cinética , Levodopa/química , Modelos Lineales , Imagen por Resonancia Magnética , Metilcelulosa/química , Modelos Químicos , Solubilidad , Estómago , Tecnología Farmacéutica/métodos
5.
Drug Dev Ind Pharm ; 30(9): 947-57, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15554219

RESUMEN

Evaluation of macromolecular polymers used as excipients for the preparation of hydrodynamically balanced systems (HBS) was carried out. Hard gelatine capsules were filled with polymeric substances belonging to various chemical groups (chitosan, sodium alginate, hydroxypropylmethycellulose--HPMC). The following properties of the HBS were investigated: density, hydration, erosion and floating force. The solvent penetration process into the HBS was visualized using magnetic resonance imaging (MRI) technique. Densities of the HBS in hydrochloric acid (0.1 M) ranged from 0.37 g/cm3 to 0.71 g/cm3. Each polymer demonstrated different hydration/erosion abilities and floating properties. The maximum floating force (F(float max)) for capsules size 0, ranged from 26.7 mN (sodium alginate) to 64.7 mN (chitosan). HBS formulations also varied in time to reach maximum floating force (T(float max)). HPMC and sodium alginate formulation reached F(float max) within half an hour after immersion, while in the case of chitosan formulations (deacetylation degree (d.d.) 66% and d.d. 93%), the time was 184 minutes and 218 minutes respectively. The floating properties of the dosage forms were reliant on type of the polymer and the medium-fasted state simulated gastric fluid (FaSSGF) or fed state simulated gastric fluid (FeSSGF). The size of the HBS influenced the floating force value. The mechanisms of erosion and swelling of the polymeric matrices play a dominant role in flotation of the dosage forms.


Asunto(s)
Sistemas de Liberación de Medicamentos , Excipientes/química , Metilcelulosa/análogos & derivados , Polímeros/química , Alginatos/química , Cápsulas , Química Farmacéutica , Quitosano/química , Composición de Medicamentos , Gelatina/química , Ácido Glucurónico/química , Ácidos Hexurónicos/química , Hidrogeles , Derivados de la Hipromelosa , Imagen por Resonancia Magnética , Metilcelulosa/química , Peso Molecular , Solventes/química , Factores de Tiempo , Agua/química
6.
Int J Pharm ; 206(1-2): 13-21, 2000 Sep 25.
Artículo en Inglés | MEDLINE | ID: mdl-11058806

RESUMEN

The formulation of ternary solid dispersions of ketoprofen with Macrogol and kollagen hydrolizate derivative as carriers was elaborated on the basis of the results of the experiments in which different methods of solid dispersion preparation (melting, solvent method, different cooling), different concentrations of drug/carriers and molecular weight of Macrogol were tested. The best solid dispersion consisted of: ketoprofen-Macrogol 6000-KLH(T) (1+8. 9+0.1) was chosen to formulate the pellets on the basis of the pharmaceutical availability of ketoprofen from solid dispersion and the physical chemical studies: thermomicroscopic, DSC and X-ray diffraction. The pellets were prepared by the extrusion and spheronization method. The mechanical properties of the pellets as well as ketoprofen released from pellets containing solid dispersion, in comparison with physical mixtures and the drug alone, were evaluated. The increase in the amount of released ketoprofen from solid dispersion pellets was 3.8-times greater than from the pellets containing the drug alone. The stability of solid dispersion pellets was satisfactory.


Asunto(s)
Antiinflamatorios no Esteroideos/química , Cetoprofeno/química , Polietilenglicoles/química , Solventes/química , Química Farmacéutica , Portadores de Fármacos , Implantes de Medicamentos , Solubilidad
8.
Pol J Pharmacol Pharm ; 40(5): 465-9, 1988.
Artículo en Inglés | MEDLINE | ID: mdl-2978177

RESUMEN

An ointment containing penetrating agents and erythromycin was devised. The rate of penetration of the antibiotic through the skin and the ointment efficacy in treatment of acne changes caused by Propionibacterium strains in animals were evaluated.


Asunto(s)
Acné Vulgar/tratamiento farmacológico , Eritromicina/farmacocinética , Animales , Eritromicina/administración & dosificación , Eritromicina/uso terapéutico , Excipientes , Masculino , Pomadas , Conejos , Absorción Cutánea
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...